my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
Amylin Pharmaceuticals is a biopharmaceutical company committed to improving lives through the discovery, development and commercialization of innovative medicines. Amylin has developed and gained approval for two first-in-class medicines for diabetes, SYMLIN(R) (pramlintide acetate) injection and B more
Amylin Pharmaceuticals, Inc. and Takeda Pharmaceutical Company Limited announced that they are discontinuing development of pramlintide/metreleptin, an investigational combination therapy for the treatment of obesity that comprises pramlintide, an analog of the natural hormone amylin, and metrelept more
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. announced that the U.S. Food and Drug Administration (FDA) has issued a complete response letter regarding the New Drug Application (NDA) for BYDUREON(TM) (exenatide extended-release for injectable suspension). In the complete r more
Amylin Pharmaceuticals, Inc. announced that Christian Weyer, MD has been appointed Senior Vice President, Research and Development. Orville Kolterman, MD, has been named Senior Vice President, Chief Medical Officer. These leadership changes will strengthen the Company's focus on preparations for a more
Introduction GlobalData, the industry analysis specialist, has released its new report, “Type 2 Diabetes - Global Drug Forecasts and Treatment Analysis to 2020”. The report is an essential source of information and analysis on the global type 2 diabetes therapeutics market. The report provides comp more
Alkermes, Inc. (ALKS) - Financial and Strategic SWOT Analysis Review Summary Alkermes, Inc., (Alkermes) is a publicly traded biotechnology company. It is engaged in developing and manufacturing of extended-release injectable, pulmonary, and oral products for the treatment of prevalent, chronic di more
How will the drug delivery sector develop from 2010, and where will you find the greatest opportunities? How will technology suppliers and drug companies benefit? We show you opportunities for revenue growth for suppliers and users of drug delivery technologies. You can have our report today, stayin more
Skip to content About Amylin Our Story Our Culture Leadership & Structure Management Team Board of Directors Strategic Partners Advisory Boards Contact Us Products SYMLIN ® (pramlintide acetate) injection BYETTA ® (exenatide) injection Patient Stories Patient Resources Patient Assistance Program more
Proteus Biomedical, Inc. Vision Company Management Team Board of Directors Technology Products Partners Contact Driving Directions Careers Background Events News News Feed You are here: Home / Company / Board of Directors Board of Directors Frank Fischer Chairman of the Board of Directors President more
Horizon Therapeutics home search sitemap Corporate Profile Senior Management Board of Directors Investors Business Development Pain Management NSAIDs and GI Side Effects Osteoarthritis Rheumatoid Arthritis Severe Asthma Polymyalgia Rheumatica Resources LODOTRA ® HZT-501 TruNoc™ HZN-602 Press Release more
Amylin Pharmaceuticals Amylin Pharmaceuticals is a biopharmaceutical company based in San Diego, CA , that was founded in 1987 . Currently, Amylin produces two drugs, Symlin (pramlintide acetate ) and Byetta (exenatide ). Amylin also is working ... more
Watchlist
This is where you can add this topic to your personal favourites
Über CHEMIE.DE
CHEMIE.DE Information Service GmbH runs specialist scientific internet portals. The secret to our success? We are familiar with what we publish.
Advertising at CHEMIE.DE
Our advertising formats support you in getting your message across to a clearly defined target audience.
© 1997-2013 CHEMIE.DE Information Service GmbH, All rights reserved
Netmeeting
